financetom
Business
financetom
/
Business
/
Amazon.com Q4 Earnings, Net Sales Rise; Q1 Outlook Set
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon.com Q4 Earnings, Net Sales Rise; Q1 Outlook Set
Feb 6, 2025 1:21 PM

04:14 PM EST, 02/06/2025 (MT Newswires) -- Amazon.com ( AMZN ) reported Q4 earnings late Thursday of $1.86 per diluted share, up from $1 a year earlier.

Analysts surveyed by FactSet expected $1.49.

Net sales for the quarter ended Dec. 31 rose to $187.79 billion from $169.96 billion a year earlier.

Analysts surveyed by FactSet expected $187.31 billion.

The company expects Q1 net sales of $151 billion and $155.5 billion. Analysts surveyed by FactSet expect $158.56 billion. The company expects operating income for the quarter between $14 billion and $18 billion, compared with $15.3 billion a year earlier.

Shares of Amazon.com ( AMZN ) were down more than 3.2% in after-hours activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Silica Holdings Reports Preliminary Q2 Results
US Silica Holdings Reports Preliminary Q2 Results
Jul 15, 2024
03:34 PM EDT, 07/15/2024 (MT Newswires) -- US Silica Holdings ( SLCA ) reported Monday preliminary Q2 net income of $18.7 million to $19.7 million. Two analysts polled by Capital IQ expect $18.7 million. The company reported preliminary sales of $317 million to $318 million. Two analysts surveyed by Capital IQ expect $340.3 million. Financial closing procedures for the three...
Revolution Medicines Projects 2024 Net Loss of $560 Million to $600 Million; Provides Latest Cancer Drug Study Data
Revolution Medicines Projects 2024 Net Loss of $560 Million to $600 Million; Provides Latest Cancer Drug Study Data
Jul 15, 2024
03:36 PM EDT, 07/15/2024 (MT Newswires) -- Revolution Medicines ( RVMD ) expects a net loss of $560 million to $600 million for full year 2024, according to a regulatory filing Monday. This includes estimated non-cash stock-based compensation expenses of $70 million to $80 million. The cash, cash equivalents and marketable securities are adequate to sustain operations until 2027. The...
Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Pulse Biosciences Enters $60 Million Equity Distribution Agreement
Jul 15, 2024
03:39 PM EDT, 07/15/2024 (MT Newswires) -- Pulse Biosciences ( PLSE ) said Monday that it entered into an equity distribution agreement with sales agents Canaccord Genuity and Needham to sell up to $60 million in common stock from time to time. Pulse Biosciences ( PLSE ) will pay up to 3.0% of the gross sales price per share sold...
Foran Up 8% After Announcing Strategic Investments By Fairfax, Agnico And Others; Makes Formal Construction Decision For Phase 1 At McIlvenna Bay And Advances Planning For Phase 2
Foran Up 8% After Announcing Strategic Investments By Fairfax, Agnico And Others; Makes Formal Construction Decision For Phase 1 At McIlvenna Bay And Advances Planning For Phase 2
Jul 15, 2024
03:31 PM EDT, 07/15/2024 (MT Newswires) -- Foran Mining Corporation ( FMCXF ) was at last look up near 9% after announcing earlier Monday a series of brokered and non-brokered strategic investments for up to $315 Million, consisting of a brokered equity private placement for which the company has received indications of interest from several of its existing shareholders, including...
Copyright 2023-2025 - www.financetom.com All Rights Reserved